Primmune Therapeutics Investors

29 investors on Angel Roster list Primmune Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Primmune Therapeutics can appear together.

Investors listed
29
With verified email
48%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 29 Primmune Therapeutics investors

The most complete profiles first. Showing 29 of 29.

  • Alexandra CantleyVerified

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 76 more

    Verified email available

  • Amy SchulmanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareAndroid

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 80 more

    Contact details available

  • Connor RyanVerified

    Venture Capital, Advisor, Private Equity Firm · United States

    SeedHealth CareE-commerceWellnessWomen Founded

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 76 more

    Verified email available

  • Dave BarrettVerified

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 84 more

    Verified email available

  • Sabrina ChiassonVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareAndroid

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 76 more

    Verified email available

  • Alan CraneVerified

    Venture Capital · United States

    Health CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 82 more

    Verified email available

  • Chris PachecoVerified

    Venture Capital · United States

    Health CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Verified email available

  • Harold FriedmanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedEnterprise SoftwareAndroid

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Verified email available

  • Mark J.Verified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedEnterprise SoftwareAndroid

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Verified email available

  • Amir Nashat

    Venture Capital, Angel/Individual, Investor · United States

    SeedPre-SeedEnergyBiotechnologyElectronic Health Records (EHR)Health and Hospital Services

    Portfolio: Athenix, AgBiome, BIND Therapeutics, Jnana Therapeutics and 15 more

    Contact details available

  • Bryce Youngren

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedArtificial Intelligence (AI)Small and Medium Businesses

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 79 more

    Contact details available

  • Darren Carroll

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Contact details available

  • Jannah Boudreaux

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Contact details available

  • Marissa Bertorelli

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareAndroid

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Contact details available

  • Brendan Hannigan

    Venture Capital · United States

    Health CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Contact details available

  • Jim Weinstein

    Venture Capital · United States

    Health CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Contact details available

  • Jon Flint

    Venture Capital · United States

    Health CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Contact details available

  • Cecilia GonzaloVerified

    Venture Capital · United States

    Health CareWomen FoundedInvestment ManagementBiotechnology

    Portfolio: Mirum Pharmaceuticals, Impact Biomedicines, NorthStar Medical Radioisotopes, Primmune Therapeutics

    Verified email available

  • James JamesVerified

    Venture Capital · United States

    Health CareWomen FoundedInvestment ManagementBiotechnology

    Portfolio: Mirum Pharmaceuticals, Impact Biomedicines, NorthStar Medical Radioisotopes, Primmune Therapeutics

    Verified email available

  • Michael BloomVerified

    Venture Capital · United States

    Health CareWomen FoundedInvestment ManagementBiotechnology

    Portfolio: Mirum Pharmaceuticals, Impact Biomedicines, NorthStar Medical Radioisotopes, Primmune Therapeutics

    Verified email available

  • Molly ScottVerified

    Venture Capital · United States

    Health CareWomen FoundedInvestment ManagementBiotechnology

    Portfolio: Mirum Pharmaceuticals, Impact Biomedicines, NorthStar Medical Radioisotopes, Primmune Therapeutics

    Verified email available

  • William CliffordVerified

    Venture Capital · United States

    Health CareWomen FoundedInvestment ManagementBiotechnology

    Portfolio: Mirum Pharmaceuticals, Impact Biomedicines, NorthStar Medical Radioisotopes, Primmune Therapeutics

    Verified email available

  • Andrew Rubinstein

    Venture Capital · United States

    Health CareWomen FoundedInvestment ManagementBiotechnology

    Portfolio: Mirum Pharmaceuticals, Impact Biomedicines, NorthStar Medical Radioisotopes, Primmune Therapeutics

    Contact details available

  • CN Chen, CFA

    Venture Capital · United States

    Health CareWomen FoundedInvestment ManagementBiotechnology

    Portfolio: Mirum Pharmaceuticals, Impact Biomedicines, NorthStar Medical Radioisotopes, Primmune Therapeutics

    Contact details available

  • Charlie McDermottVerified

    Angel/Individual · United States

    Health CareBiotechnologyMarket Research

    Portfolio: Primmune Therapeutics

    Verified email available

  • Kristian Wiggert

    Venture Capital · United States

    Health CareWomen FoundedInvestment ManagementBiotechnology

    Portfolio: Mirum Pharmaceuticals, Impact Biomedicines, NorthStar Medical Radioisotopes, Primmune Therapeutics

    Contact details available

  • Sarah Drew Siber

    Venture Capital · United States

    Health CareWomen FoundedInvestment ManagementBiotechnology

    Portfolio: Mirum Pharmaceuticals, Impact Biomedicines, NorthStar Medical Radioisotopes, Primmune Therapeutics

    Contact details available

  • Sean Fillion

    Venture Capital · United States

    Health CareWomen FoundedInvestment ManagementBiotechnology

    Portfolio: Mirum Pharmaceuticals, Impact Biomedicines, NorthStar Medical Radioisotopes, Primmune Therapeutics

    Contact details available

  • Mary Wheeler

    Venture Capital, Micro VC · United States

    Health CareAndroidSoftwareBiotechnology

    Portfolio: Primmune Therapeutics

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Primmune Therapeutics investors are on Angel Roster?

Angel Roster lists 29 Primmune Therapeutics investors. 14 of them (48%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (28), Private Equity Firms (6) and Angel Investors (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Primmune Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (10) and Pre-Seed (9).

Where are Primmune Therapeutics investors based?

Most are based in the United States (29).

Which companies have Primmune Therapeutics investors backed?

The most-backed portfolio companies among them are Jnana (17), Scholar Rock (17), Dewpoint Therapeutics (17), 1366 Technologies (17) and Freenome (17).

How do I contact Primmune Therapeutics investors?

Create a free Angel Roster account to search and filter all 29, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.